Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry.
Lotte S SpekhorstLieneke F M AriënsJorien van der SchaftDaphne S BakkerMarijke KamsteegAlbert J OostingIlona de RidderAnnemiek SloeserwijGeertruida L E RomeijnMarlies de GraafInge HaeckJudith L ThijsMarie L A SchuttelaarMarjolein de Bruin-WellerPublished in: Allergy (2020)